TherapeuticsMD (TXMD) Q4 2024 Annual Earnings
TXMD·Reported March 27, 2025
TherapeuticsMD reported Q4 2024 revenue of $667.0K, missed analyst consensus of $2.3M by $1.6M. Diluted EPS came in at $0.02, missed the $0.04 consensus by $0.02.
Revenue
$667.0Kmissed by $1.6M
Consensus: $2.3MDiluted EPS
$0.02missed by $0.02
Consensus: $0.04
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about TherapeuticsMD's Q4 2024 earnings report.
TherapeuticsMD (TXMD) reported Q4 2024 earnings on March 27, 2025.
TherapeuticsMD reported revenue of $667.0K and diluted EPS of $0.02 for Q4 2024.
Revenue missed the consensus estimate of $2.3M by $1.6M. EPS missed the consensus estimate of $0.04 by $0.02.
You can read the 10-K periodic report (0001013762-25-003442) directly on SEC EDGAR. The filing index links above go to sec.gov.